[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100452304":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":28,"responsibleParty":44,"collaborators":10,"id":47,"slug":10,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":48,"sex":54,"minAge":55,"maxAge":10,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Odense University Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"transgender women",null,"transgender women eligeble to start gender affirming hormone treatment",[13],"Other: standard treatment",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"standard treatment","starndard treatment for transgender women",[9],[20],{"name":21,"affiliation":5,"role":22},"Dorte Glintborg","PRINCIPAL_INVESTIGATOR",[24],{"name":21,"role":25,"phone":26,"phoneExt":10,"email":27},"CONTACT","+4565411807","dorte.glintborg@rsyd.dk",[29],{"facility":30,"status":31,"city":32,"state":10,"zip":33,"country":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"OdenseUH","RECRUITING","Odense","5230","Denmark",{"type":36,"coordinates":37},"Point",[38,39],10.38831,55.39594,{"lat":39,"lon":38},[42],{"name":43,"role":22,"phone":10,"phoneExt":10,"email":10},"Marianne Andersen, DMSci",{"type":22,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Marianne Andersen","Clinical professor","100452304",false,"NCT05169762","Feminizing Treatment in Transgender Women and Non-binary Persons","Feminizing Treatment in Transgender Women and Non-binary Persons BODY IDENTITY CLINIC - ESTROGEN","BIC-Estrogen","Inclusion Criteria:\n\n* assigned male at birth and eligeble for gender affirming feminizing treatment\n\nExclusion Criteria:\n\nnone\n\n\\-","MALE","18 Years",{"count":57,"type":58},100,"ESTIMATED","OBSERVATIONAL","Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.",[62],"Transgenderism",[64,65,66],"gender affirming hormone treatment","estrogen","cardiovascular risk","2025-03-18",{"date":69,"type":70},"2025-03-21","ACTUAL",{"date":72,"type":70},"2022-02-01",{"date":74,"type":58},"2035-09-01",{"name":5,"class":6},1]